Ainos, Inc. (NASDAQ:AIMD) Short Interest Update

Ainos, Inc. (NASDAQ:AIMD) saw a significant drop in short interest in January. As of January 15th, there was short interest totaling 17,674 shares, a drop of 12.7% from the December 31st total of 20,236 shares. Based on an average daily trading volume, of 19,581 shares, the days-to-cover ratio is presently 0.9 days. Approximately 0.4% of the shares of the stock are short sold. Approximately 0.4% of the shares of the stock are short sold. Based on an average daily trading volume, of 19,581 shares, the days-to-cover ratio is presently 0.9 days.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Ainos in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.

Ainos Stock Performance

Shares of NASDAQ:AIMD opened at $2.04 on Thursday. The company has a current ratio of 2.96, a quick ratio of 2.67 and a debt-to-equity ratio of 1.10. Ainos has a 1-year low of $1.61 and a 1-year high of $4.50. The stock has a market capitalization of $9.81 million, a P/E ratio of -0.51 and a beta of 2.50. The business has a 50-day moving average price of $2.00 and a two-hundred day moving average price of $2.83.

Ainos (NASDAQ:AIMD) last issued its earnings results on Thursday, November 13th. The company reported ($0.64) earnings per share (EPS) for the quarter. The firm had revenue of $0.00 million for the quarter.

Insider Activity

In related news, major shareholder Carbon Nano Technology Taiwan sold 46,000 shares of the company’s stock in a transaction dated Wednesday, January 28th. The shares were sold at an average price of $2.17, for a total transaction of $99,820.00. Following the transaction, the insider owned 989,925 shares in the company, valued at $2,148,137.25. This represents a 4.44% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders sold 47,281 shares of company stock valued at $102,152 over the last three months. Insiders own 9.79% of the company’s stock.

Institutional Trading of Ainos

A hedge fund recently bought a new stake in Ainos stock. Two Sigma Investments LP purchased a new stake in Ainos, Inc. (NASDAQ:AIMD) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 23,008 shares of the company’s stock, valued at approximately $80,000. Two Sigma Investments LP owned 0.48% of Ainos as of its most recent SEC filing.

About Ainos

Ainos, Inc (NASDAQ: AIMD) is a clinical‐stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI‐401, is an inhaled formulation of ibuprofen in a dry powder format.